Cheapest Retatrutide UK
Looking for the cheapest Retatrutide in the UK? Learn what to expect, how pricing may work, and how it could compare to current treatments.
Whether you have read about retatrutide and want to know what the cheapest UK price will be, or have been offered it by a non-pharmacy seller and want to gauge the going rate, this guide explains why no licensed UK price for retatrutide exists yet and what to expect when one eventually does. LetsLoseWeight is an independent comparison site; we do not prescribe medication.
Important: Retatrutide is an investigational medicine. As of this guide's last review, it is not licensed by the MHRA and is not available from any regulated UK pharmacy. There is therefore no legitimate UK price for retatrutide at present. Anyone offering retatrutide for sale in the UK outside a registered clinical trial is doing so unlawfully.
There is no "cheapest UK price" for retatrutide
A licensed UK price requires a licensed UK supply chain. Until retatrutide receives MHRA marketing authorisation and is supplied through licensed wholesalers to GPhC-registered pharmacies, there is no legitimate UK retail price to compare.
Anyone advertising retatrutide for sale in the UK at a specific price is doing so outside the regulated supply chain, and the safety risks of buying from those sellers are substantial. The MHRA has warned consumers about buying prescription-only weight-loss medicines without a prescription. Those warnings apply with extra force to medicines that are not approved at all.
For a fuller explanation of why retatrutide is not legitimately available, see our buy retatrutide UK guide.
What retatrutide will likely cost when licensed
Once retatrutide is approved for UK use — assuming phase 3 trials succeed and MHRA marketing authorisation follows — its pricing will be set by the manufacturer (Eli Lilly) and individual pharmacies. Drawing comparisons from related medicines:
- Mounjaro (tirzepatide) is currently priced at around £130–£300 per month privately, depending on dose and provider
- Wegovy (semaglutide) is priced at around £130–£300 per month privately, depending on dose and provider
- Retatrutide is from the same manufacturer as Mounjaro and is technically more complex (a triple receptor agonist rather than a dual)
It is reasonable to expect retatrutide pricing to fall in a broadly similar range to existing weight-management medicines once licensed, possibly at the higher end. NICE may then assess it for NHS use through a separate process.
These are forward-looking expectations, not guarantees. Actual pricing will depend on manufacturer strategy, NHS negotiation, market competition, and several other factors.
Why "cheapest now" is the wrong question
The relevant question right now is not "what's the cheapest retatrutide?" but "is buying retatrutide right now a good idea?" The honest answer is no, because:
- No regulatory approval in the UK or major Western markets (as of this guide's review)
- No GPhC-registered pharmacy can supply it
- No clinical assessment for contraindications
- No safety net if something goes wrong
- No quality control — the vials may not contain retatrutide, may be incorrectly dosed, or may be contaminated
- No insurance protection if the product harms you
The numbers behind retatrutide's phase 2 trial — around 24% average weight loss at the 12mg dose — apply to trial-grade product administered to selected trial participants, not to whatever is in an unregulated vial. Any "cheap" retatrutide bought from an unregulated source carries no guarantee of being the medicine on the label.
For the safety risks in detail, see our buy retatrutide UK guide and our retatrutide side effects guide.
The cheapest legitimate option right now
If your priority is the lowest cost weight-management injection through a regulated UK provider, the question is best answered by comparing the licensed alternatives:
- Cheapest Mounjaro UK — see our cheapest Mounjaro UK guide and Mounjaro price comparison
- Cheapest Wegovy UK — see our cheapest Wegovy UK guide and Wegovy price comparison
- NHS access — if eligible, NHS-funded Mounjaro under TA1026 or Wegovy under TA875 costs only the standard prescription charge (£9.90 in 2025/26 in England; free in Scotland, Wales and Northern Ireland)
Mounjaro in particular has shown the largest average weight loss of any currently licensed weight-management medicine — larger on average than retatrutide's eventual licensed competitor will need to demonstrate to be approved. The difference between licensed Mounjaro and unlicensed retatrutide isn't just about price; it's about regulation, quality, and safety.
What to do if you have already bought retatrutide
If you have already bought retatrutide from an unregulated seller:
- Stop using it. The vials may not contain what is claimed, may be incorrectly dosed, or may be contaminated.
- If you have side effects, contact your GP or NHS 111. Mention what you have been using.
- Report the seller to the MHRA via the Yellow Card scheme or to Trading Standards. This helps protect other consumers.
- Do not return to the seller for a refund as a justification for continuing to buy. The seller is operating unlawfully.
What to do if you want retatrutide specifically
The legitimate options if retatrutide is the medicine you specifically want:
- Take part in a clinical trial. The TRIUMPH trial programme is recruiting in some countries. For UK trial sites, see the National Institute for Health and Care Research's Be Part of Research portal. Participation is free, monitored, and the only legal way to access retatrutide in the UK at this time.
- Wait for MHRA approval. When retatrutide is approved, this site will list regulated UK providers and their prices. Until then, no legitimate price exists.
- Consider Mounjaro as a licensed alternative. Tirzepatide is from the same manufacturer (Eli Lilly), uses two of the three receptors retatrutide targets, and is the closest currently licensed option.
When to revisit retatrutide pricing
Once retatrutide is approved for UK use, this page will be updated with provider-by-provider pricing across regulated UK pharmacies, alongside our other retatrutide content. Until then, "cheapest retatrutide UK" is a question without a legitimate answer.
Frequently asked questions
Why is retatrutide so much more expensive on unregulated sites than Mounjaro or Wegovy?
Unregulated sellers price freely. Some price below licensed Mounjaro/Wegovy to attract buyers; some price above. Either way, the price has no relationship to legitimate UK supply chain economics, and the product itself has no quality guarantees.
Will retatrutide be cheaper than Mounjaro when it's licensed?
There is no published indication that it will. Triple agonists are technically more complex than dual agonists, and Mounjaro's pricing already reflects substantial manufacturer margin. It is more likely retatrutide will be similarly priced or more expensive than Mounjaro, at least initially.
Will the NHS fund retatrutide?
Possibly — if approved by the MHRA and then by NICE through a technology appraisal. NHS access criteria are typically narrower than the licensed indication, similar to current restrictions on Mounjaro and Wegovy.
Can I buy retatrutide cheaply from another country?
No — at least, not legally in the UK. Importing prescription medicines without a prescription is unlawful, and customs may seize parcels. Even where retatrutide may be obtainable in another country, this does not make it legal to import or use in the UK.
Next steps
- Why retatrutide is not legitimately for sale: Buy retatrutide UK
- Latest UK availability status: Retatrutide price UK
- How retatrutide is designed to work: How Retatrutide Works
- Currently licensed alternatives: Cheapest Mounjaro UK · Cheapest Wegovy UK
- Compare prices: Mounjaro price comparison · Wegovy price comparison
Sources
- MHRA. MHRA warns public against buying prescription-only weight loss medicines without a prescription. https://www.gov.uk/government/news/mhra-warns-public-against-buying-prescription-only-weight-loss-medicines-without-a-prescription
- MHRA. Yellow Card scheme. https://yellowcard.mhra.gov.uk/
- Jastreboff AM, Kaplan LM, Frias JP, et al. Triple-hormone-receptor agonist retatrutide for obesity — a phase 2 trial. New England Journal of Medicine. 2023;389(6):514–526. https://www.nejm.org/doi/full/10.1056/NEJMoa2301972
- NICE. Tirzepatide for managing overweight and obesity (TA1026). https://www.nice.org.uk/guidance/ta1026
- NICE. Semaglutide for managing overweight and obesity (TA875). https://www.nice.org.uk/guidance/ta875
- NIHR. Be Part of Research. https://bepartofresearch.nihr.ac.uk/
This guide is for general information only. Retatrutide is not currently approved or available in the UK outside clinical trials. Anyone offering it for sale in the UK is operating unlawfully.
Get weekly weight loss tips
Join our newsletter for provider updates, expert guidance, and exclusive offers — no spam.
Subscribe free